Repression of the central splicing regulator RBFox2 is functionally linked to pressure overload-induced heart failure

Cell Reports

Volumn 10, Issue 9, 2015, Pages 1521-1533

  Wei, Chaoliang ^a   Qiu, Jinsong ^a   Zhou, Yu ^a   Xue, Yuanchao ^a   Hu, Jing ^a   Ouyang, Kunfu ^b   Banerjee, Indroneal ^b   Zhang, Caimei ^d   Chen, Biyi ^d   Li, Hairi ^a   Chen, Ju ^b   Song, Long Sheng ^d   Fu, Xiang Dong ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c University of California San Diego   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN RBFOX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; BINDING AFFINITY; CHROMATIN IMMUNOPRECIPITATION; CONFOCAL MICROSCOPY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXCITATION CONTRACTION COUPLING; FEMALE; GENE; GENE MAPPING; HEART FAILURE; HEART VENTRICLE OVERLOAD; INTRON; MALE; MORPHOLOGY; MORTALITY; MOUSE; NONHUMAN; PHENOTYPE; POLYADENYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RBFOX2 GENE; RNA SPLICING; SARCOPLASMIC RETICULUM;

MUS; RODENTIA;

EID: 84924631336     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.02.013     Document Type: Article

References (58)

1. Aguilar F., Belmonte S.L., Ram R., Noujaim S.F., Dunaevsky O., Protack T.L., Jalife J., Todd Massey H., Gertler F.B., Blaxall B.C. Mammalian enabled (Mena) is a critical regulator of cardiac function. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H1841-H1852.
2. Bienengraeber M., Olson T.M., Selivanov V.A., Kathmann E.C., O'Cochlain F., Gao F., Karger A.B., Ballew J.D., Hodgson D.M., Zingman L.V., et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat. Genet. 2004, 36:382-387.
3. Chen J., Kubalak S.W., Chien K.R. Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development 1998, 125:1943-1949.
4. Chen Y., Craigen W.J., Riley D.J. Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1. Cell Cycle 2009, 8:257-267.
5. Cheng H., Lederer W.J. Calcium sparks. Physiol. Rev. 2008, 88:1491-1545.
6. Cheng H., Kimura K., Peter A.K., Cui L., Ouyang K., Shen T., Liu Y., Gu Y., Dalton N.D., Evans S.M., et al. Loss of enigma homolog protein results in dilated cardiomyopathy. Circ. Res. 2010, 107:348-356.
7. Colomer J.M., Mao L., Rockman H.A., Means A.R. Pressure overload selectively up-regulates Ca2+/calmodulin-dependent protein kinase II invivo. Mol. Endocrinol. 2003, 17:183-192.
8. Diwan A., Dorn G.W. Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda) 2007, 22:56-64.
9. Du H., Cline M.S., Osborne R.J., Tuttle D.L., Clark T.A., Donohue J.P., Hall M.P., Shiue L., Swanson M.S., Thornton C.A., Ares M. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol. 2010, 17:187-193.
10. Fogel B.L., Wexler E., Wahnich A., Friedrich T., Vijayendran C., Gao F., Parikshak N., Konopka G., Geschwind D.H. RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum. Mol. Genet. 2012, 21:4171-4186.
11. Fu X.D., Ares M. Context-dependent control of alternative splicing by RNA-binding proteins. Nat. Rev. Genet. 2014, 15:689-701.
12. Fukumura K., Kato A., Jin Y., Ideue T., Hirose T., Kataoka N., Fujiwara T., Sakamoto H., Inoue K. Tissue-specific splicing regulator Fox-1 induces exon skipping by interfering E complex formation on the downstream intron of human F1gamma gene. Nucleic Acids Res. 2007, 35:5303-5311.
13. Gallagher T.L., Arribere J.A., Geurts P.A., Exner C.R., McDonald K.L., Dill K.K., Marr H.L., Adkar S.S., Garnett A.T., Amacher S.L., Conboy J.G. Rbfox-regulated alternative splicing is critical for zebrafish cardiac and skeletal muscle functions. Dev. Biol. 2011, 359:251-261.
14. Gehman L.T., Stoilov P., Maguire J., Damianov A., Lin C.H., Shiue L., Ares M., Mody I., Black D.L. The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain. Nat. Genet. 2011, 43:706-711.
15. Gehman L.T., Meera P., Stoilov P., Shiue L., O'Brien J.E., Meisler M.H., Ares M., Otis T.S., Black D.L. The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. Genes Dev. 2012, 26:445-460.
16. Gehmlich K., Pinotsis N., Hayess K., van der Ven P.F., Milting H., El Banayosy A., Körfer R., Wilmanns M., Ehler E., Fürst D.O. Paxillin and ponsin interact in nascent costameres of muscle cells. J.Mol. Biol. 2007, 369:665-682.
17. Giudice J., Xia Z., Wang E.T., Scavuzzo M.A., Ward A.J., Kalsotra A., Wang W., Wehrens X.H., Burge C.B., Li W., Cooper T.A. Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development. Nat. Commun. 2014, 5:3603.
18. Guo A., Zhang X., Iyer V.R., Chen B., Zhang C., Kutschke W.J., Weiss R.M., Franzini-Armstrong C., Song L.S. Overexpression of junctophilin-2 does not enhance baseline function but attenuates heart failure development after cardiac stress. Proc. Natl. Acad. Sci. USA 2014, 111:12240-12245.
19. Hayakawa M., Sakashita E., Ueno E., Tominaga S., Hamamoto T., Kagawa Y., Endo H. Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA. J.Biol. Chem. 2002, 277:6974-6984.
20. Hill J.A., Karimi M., Kutschke W., Davisson R.L., Zimmerman K., Wang Z., Kerber R.E., Weiss R.M. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 2000, 101:2863-2869.
21. Jangi M., Boutz P.L., Paul P., Sharp P.A. Rbfox2 controls autoregulation in RNA-binding protein networks. Genes Dev. 2014, 28:637-651.
22. Kalsotra A., Cooper T.A. Functional consequences of developmentally regulated alternative splicing. Nat. Rev. Genet. 2011, 12:715-729.
23. Kalsotra A., Xiao X., Ward A.J., Castle J.C., Johnson J.M., Burge C.B., Cooper T.A. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc. Natl. Acad. Sci. USA 2008, 105:20333-20338.
24. Kaynak B., von Heydebreck A., Mebus S., Seelow D., Hennig S., Vogel J., Sperling H.P., Pregla R., Alexi-Meskishvili V., Hetzer R., et al. Genome-wide array analysis of normal and malformed human hearts. Circulation 2003, 107:2467-2474.
25. Kim K.K., Adelstein R.S., Kawamoto S. Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors. J.Biol. Chem. 2009, 284:31052-31061.
26. Kontrogianni-Konstantopoulos A., Bloch R.J. The hydrophilic domain of small ankyrin-1 interacts with the two N-terminal immunoglobulin domains of titin. J.Biol. Chem. 2003, 278:3985-3991.
27. Krenz M., Robbins J. Impact of beta-myosin heavy chain expression on cardiac function during stress. J.Am. Coll. Cardiol. 2004, 44:2390-2397.
28. Kuroyanagi H. Fox-1 family of RNA-binding proteins. Cell. Mol. Life Sci. 2009, 66:3895-3907.
29. Kwiatkowski A.P., McGill J.M. Alternative splice variant of gamma-calmodulin-dependent protein kinase II alters activation by calmodulin. Arch. Biochem. Biophys. 2000, 378:377-383.
30. Li H., Qiu J., Fu X.D. RASL-seq for massively parallel and quantitative analysis of gene expression. Curr. Protoc. Mol. Biol. 2012, Chapter 4:1-9.
31. Marber M.S., Rose B., Wang Y. The p38 mitogen-activated protein kinase pathway-a potential target for intervention in infarction, hypertrophy, and heart failure. J.Mol. Cell. Cardiol. 2011, 51:485-490.
32. Melendez J., Turner C., Avraham H., Steinberg S.F., Schaefer E., Sussman M.A. Cardiomyocyte apoptosis triggered by RAFTK/pyk2 via Src kinase is antagonized by paxillin. J.Biol. Chem. 2004, 279:53516-53523.
33. Muthuchamy M., Pajak L., Howles P., Doetschman T., Wieczorek D.F. Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos. Mol. Cell. Biol. 1993, 13:3311-3323.
34. Muthuchamy M., Boivin G.P., Grupp I.L., Wieczorek D.F. Beta-tropomyosin overexpression induces severe cardiac abnormalities. J.Mol. Cell. Cardiol. 1998, 30:1545-1557.
35. Ponthier J.L., Schluepen C., Chen W., Lersch R.A., Gee S.L., Hou V.C., Lo A.J., Short S.A., Chasis J.A., Winkelmann J.C., Conboy J.G. Fox-2 splicing factor binds to a conserved intron motif to promote inclusion of protein 4.1R alternative exon 16. J.Biol. Chem. 2006, 281:12468-12474.
36. Reddy S., Zhao M., Hu D.Q., Fajardo G., Hu S., Ghosh Z., Rajagopalan V., Wu J.C., Bernstein D. Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure. Physiol. Genomics 2012, 44:562-575.
37. Rosenzweig R., Bronner V., Zhang D., Fushman D., Glickman M.H. Rpn1 and Rpn2 coordinate ubiquitin processing factors at proteasome. J.Biol. Chem. 2012, 287:14659-14671.
38. Sato P.Y., Coombs W., Lin X., Nekrasova O., Green K.J., Isom L.L., Taffet S.M., Delmar M. Interactions between ankyrin-G, Plakophilin-2, and Connexin43 at the cardiac intercalated disc. Circ. Res. 2011, 109:193-201.
39. Schenck A., Bardoni B., Langmann C., Harden N., Mandel J.L., Giangrande A. CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron 2003, 38:887-898.
40. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamrom B., Yoon S., Krasnitz A., Kendall J., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
41. Singh R.K., Xia Z., Bland C.S., Kalsotra A., Scavuzzo M.A., Curk T., Ule J., Li W., Cooper T.A. Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis. Mol. Cell 2014, 55:592-603.
42. Stagg M.A., Carter E., Sohrabi N., Siedlecka U., Soppa G.K., Mead F., Mohandas N., Taylor-Harris P., Baines A., Bennett P., et al. Cytoskeletal protein 4.1R affects repolarization and regulates calcium handling in the heart. Circ. Res. 2008, 103:855-863.
43. Stunnenberg B.C., Deinum J., Links T.P., Wilde A.A., Franssen H., Drost G. Cardiac arrhythmias in hypokalemic periodic paralysis: Hypokalemia as only cause?. Muscle Nerve 2014, 50:327-332.
44. Sun Z., Tong G., Ma N., Li J., Li X., Li S., Zhou J., Xiong L., Cao F., Yao L., et al. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury. Basic Res. Cardiol. 2013, 108:341.
45. van Berlo J.H., Maillet M., Molkentin J.D. Signaling effectors underlying pathologic growth and remodeling of the heart. J.Clin. Invest. 2013, 123:37-45.
46. Venables J.P., Klinck R., Koh C., Gervais-Bird J., Bramard A., Inkel L., Durand M., Couture S., Froehlich U., Lapointe E., et al. Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 2009, 16:670-676.
47. Wang E.T., Cody N.A., Jog S., Biancolella M., Wang T.T., Treacy D.J., Luo S., Schroth G.P., Housman D.E., Reddy S., et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 2012, 150:710-724.
48. Wilson S.M., Bhattacharyya B., Rachel R.A., Coppola V., Tessarollo L., Householder D.B., Fletcher C.F., Miller R.J., Copeland N.G., Jenkins N.A. Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nat. Genet. 2002, 32:420-425.
49. Xu X., Fu X.D. Conditional knockout mice to study alternative splicing invivo. Methods 2005, 37:387-392.
50. Yamamoto T., Shirayama T., Sakatani T., Takahashi T., Tanaka H., Takamatsu T., Spitzer K.W., Matsubara H. Enhanced activity of ventricular Na+-HCO3- cotransport in pressure overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1254-H1264.
51. Yang R.F., Zhao G.W., Liang S.T., Zhang Y., Sun L.H., Chen H.Z., Liu D.P. Mitofilin regulates cytochrome c release during apoptosis by controlling mitochondrial cristae remodeling. Biochem. Biophys. Res. Commun. 2012, 428:93-98.
52. Yeo G.W., Coufal N.G., Liang T.Y., Peng G.E., Fu X.D., Gage F.H. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol. 2009, 16:130-137.
53. Yung C.K., Halperin V.L., Tomaselli G.F., Winslow R.L. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics 2004, 83:281-297.
54. Zhang C., Zhang Z., Castle J., Sun S., Johnson J., Krainer A.R., Zhang M.Q. Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev. 2008, 22:2550-2563.
55. Zhao M., Chow A., Powers J., Fajardo G., Bernstein D. Microarray analysis of gene expression after transverse aortic constriction in mice. Physiol. Genomics 2004, 19:93-105.
56. Zheng M., Cheng H., Li X., Zhang J., Cui L., Ouyang K., Han L., Zhao T., Gu Y., Dalton N.D., et al. Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death. Hum. Mol. Genet. 2009, 18:701-713.
57. Zhou Z., Qiu J., Liu W., Zhou Y., Plocinik R.M., Li H., Hu Q., Ghosh G., Adams J.A., Rosenfeld M.G., Fu X.D. The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Mol. Cell 2012, 47:422-433.
58. Zhu B., Ramachandran B., Gulick T. Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain. J.Biol. Chem. 2005, 280:28749-28760.